摘要
目的:研究缺血修饰蛋白(IMA)在DVT治疗中的应用意义.方法:通过对我院收治的30例确诊为下肢深静脉血栓(DVT)的患者进行分组采血,检测其血中IMA、Hs-CRP和D-二聚体(D-D)的含量,并对其与病情变化之间的关系进行相关分析,比较IMA相对其他两种血清学指标对于DVT治疗的意义.结果:IMA在评价临床疗效时,变化较其他两种指标更显著(P=0.01),其他两种指标的P值分别为0.04和0.03.说明IMA对下肢深静脉的治疗效果评价很有价值.结论:IMA可以作为评价DVT治疗效果的依据.
AIM： To investigate the application value of ischemia-modified protein （IMA） in treating lower extremity deep vein thrombosis （LEDVT）. METHODS： 30 cases with lower extremity deep vein thrombosis confirmed by our hospital were divided into groups. Blood was taken to measure the content of IMA, Hs- CRP and D-D, and the relationship between IMA, Hs-CRP, D-D and patient＇s condition was analysed. Comparison among values of IMA for curing LEDVT and the other two serum markers was made. RESULTS： The alternation of IMA was more significant than the other two serum markers when they were used for evaluating the clinical efficacy （ P = 0.01 ）, and P values of the other two serum markers were 0. 04, 0. 03 respectively. This result showed that IMA was more valuable in evaluating effect in treat- ment of LEDVT. CONCLUSION ： IMA can be considered as the basis to evaluate the clinical efficacy of LEDVT.
出处
《转化医学电子杂志》
2015年第1期106-108,共3页
E-Journal of Translational Medicine
